Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)

Clinical trial NCT05177133 · RECRUITING

Trial details

NCT number: NCT05177133
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Esophageal Adenocarcinoma

Start date: 2021-11-05
Primary completion: 2025-05-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.